NPs Basic Information

Name
Tricycloalternarene 2a
Molecular Formula C21H30O4
IUPAC Name*
5-hydroxy-1-[(E)-7-hydroxy-6-methylhept-5-en-2-yl]-3a-methyl-3,5,6,7,9,9a-hexahydrocyclopenta[b]chromen-8-one
SMILES
CC(CC/C=C(\C)/CO)C1=CCC2(C1CC3=C(O2)C(CCC3=O)O)C
InChI
InChI=1S/C21H30O4/c1-13(12-22)5-4-6-14(2)15-9-10-21(3)17(15)11-16-18(23)7-8-19(24)20(16)25-21/h5,9,14,17,19,22,24H,4,6-8,10-12H2,1-3H3/b13-5+
InChIKey
BDMIMSPBTFWTBC-WLRTZDKTSA-N
Synonyms
Tricycloalternarene 2a; 103873-60-5; 3,3a,6,7,9,9a-hexahydro-5-hydroxy-1[(e)-7-hydroxy-6-methylhept-5-en-2-yl]-3a-methylcyclopenta[b]chromen-8(5h)-one; Cyclopenta(b)(1)benzopyran-8(3H)-one, 3a,5,6,7,9,9a-hexahydro-5-hydroxy-1-(6-hydroxy-1,5-dimethyl-4-hexenyl)-3a-methyl-
CAS 103873-60-5
PubChem CID 6443494
ChEMBL ID NA
*Note: the IUPAC Name was collected from PubChem.
Chemical Classification:
  • Kingdom: Organic compounds
    • Superclass: Lipids and lipid-like mol
      • Class: Prenol lipids
        • Subclass: Sesquiterpenoids
          • Direct Parent: Sesquiterpenoids

ClassyFire Version 1.0
PMID:27867422

NPs Species Source

Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference
Endophyte ID Endophyte Name Family Genus Taxonomy ID GenBank ID Closest GenBank ID Reference

NPs Content

*Note: The vaules in Content Percentage are calculated by dividing the content value by the maximum content value in NP Content.
**Note: The units with different NP content, due to their incomparable values, are separated into different tables.

NPs Biological Activity

Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name
Bioactivity Name Target ID Target Name Target Type Target Organism Target Organism ID Potency of Bioactivity Activity Type Value Unit Endophyte ID Endophyte Name

NPs Physi-Chem Properties

Molecular Weight: 346.5 ALogp: 2.1
HBD: 2 HBA: 4
Rotatable Bonds: 5 Lipinski's rule of five: Accepted
Polar Surface Area: 66.8 Aromatic Rings: 3
Heavy Atoms: 25 QED Weighted: 0.733

NPs ADMET Properties*

ADMET: Absorption

Caco-2 Permeability: -4.508 MDCK Permeability: 0.00002150
Pgp-inhibitor: 0.023 Pgp-substrate: 0.005
Human Intestinal Absorption (HIA): 0.149 20% Bioavailability (F20%): 0.907
30% Bioavailability (F30%): 0.023

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB): 0.785 Plasma Protein Binding (PPB): 78.92%
Volume Distribution (VD): 1.333 Fu: 10.99%

ADMET: Metabolism

CYP1A2-inhibitor: 0.018 CYP1A2-substrate: 0.195
CYP2C19-inhibitor: 0.021 CYP2C19-substrate: 0.581
CYP2C9-inhibitor: 0.023 CYP2C9-substrate: 0.221
CYP2D6-inhibitor: 0.005 CYP2D6-substrate: 0.594
CYP3A4-inhibitor: 0.435 CYP3A4-substrate: 0.261

ADMET: Excretion

Clearance (CL): 15.152 Half-life (T1/2): 0.637

ADMET: Toxicity

hERG Blockers: 0.003 Human Hepatotoxicity (H-HT): 0.323
Drug-inuced Liver Injury (DILI): 0.317 AMES Toxicity: 0.008
Rat Oral Acute Toxicity: 0.576 Maximum Recommended Daily Dose: 0.527
Skin Sensitization: 0.042 Carcinogencity: 0.882
Eye Corrosion: 0.004 Eye Irritation: 0.026
Respiratory Toxicity: 0.714
*Note: the ADMET properties was calculated by ADMETlab 2.0. Reference: PMID: 33893803.

Similar Compounds*

Compounds similar to EMNPD with top10 similarity:

Similar NPs Similar Drugs
NPs ID NPs 2D Structure Similarity Score TTD ID Drug 2D Structure Similarity Score
ENC001868 0.792 D0T2PL 0.238
ENC005805 0.792 D04VIS 0.234
ENC005807 0.792 D02VPX 0.231
ENC003211 0.704 D08SVH 0.228
ENC003123 0.655 D0K5WS 0.225
ENC005806 0.628 D0L7AS 0.222
ENC004443 0.624 D04ATM 0.221
ENC003212 0.551 D0Y7IU 0.220
ENC003124 0.511 D04QNO 0.220
ENC003577 0.505 D05BTM 0.218
*Note: the compound similarity was calculated by RDKIT.